Jinping Qiao

Dr. Jinping Qiao


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 December 2016 in Nutrients
Verified
Journal Article
Open access
PDF file
JCJianhua Cao
Jianhua Cao
JHJie Han
Jie Han
HXHao Xiao
Hao Xiao
JQJinping Qiao
Jinping Qiao
MHMei Han
Mei Han
Multidrug resistance and various adverse side effects have long been major problems in cancer chemotherapy. Recently, chemotherapy has gradually transitioned from mono-substance therapy to multidrug therapy. As a result, the drug cocktail strategy has gained more recognition and wider use. It is believed that properly-formulated drug combinations have greater therapeutic efficacy than single drugs. Tea is a popular beverage consumed by cancer patients and the general public for its perceived health benefits. The major bioactive molecules in green tea are catechins, a class of flavanols. The combination of green tea extract or green tea catechins and anticancer compounds has been paid more attention in cancer treatment. Previous studies demonstrated that the combination of chemotherapeutic drugs and green tea extract or tea polyphenols could synergistically enhance treatment efficacy and reduce the adverse side effects of anticancer drugs in cancer patients. In this review, we summarize the experimental evidence regarding the effects of green tea-derived polyphenols in conjunction with chemotherapeutic drugs on anti-tumor activity, toxicology, and pharmacokinetics. We believe that the combination of multidrug cancer treatment with green tea catechins may improve treatment efficacy and diminish negative side effects.

11 July 2019 in Phytochemistry Reviews
Verified
Journal Article
Closed access
PDF file
YZYubo Zhang
Yubo Zhang
HLHuajun Li
Huajun Li
JZJing Zhang
Jing Zhang
CZChaoran Zhao
Chaoran Zhao
SLShuai Lu
Shuai Lu
MHMei Han
Mei Han

17 December 2016 in Molecules
Verified
Journal Article
Open access
PDF file
YCYingqian Ci
Yingqian Ci
JQJinping Qiao
Jinping Qiao
MHMei Han
Mei Han
Metastatic cancers are the main cause of cancer-related death. In breast primary cancer, the five-year survival rate is close to 100%; however, for metastatic breast cancer, that rate drops to a mere 25%, due in part to the paucity of effective therapeutic options for treating metastases. Several in vitro and in vivo studies have indicated that consumption of natural polyphenols significantly reduces the risk of cancer metastasis. Therefore, this review summarizes the research findings involving the molecular mechanisms and metabolomics of natural polyphenols and how they may be blocking breast cancer metastasis. Most natural polyphenols are thought to impair breast cancer metastasis through downregulation of MMPs expression, interference with the VEGF signaling pathway, modulation of EMT regulator, inhibition of NF-κB and mTOR expression, and other related mechanisms. Intake of natural polyphenols has been shown to impact endogenous metabolites and complex biological metabolic pathways in vivo. Breast cancer metastasis is a complicated process in which each step is modulated by a complex network of signaling pathways. We hope that by detailing the reported interactions between breast cancer metastasis and natural polyphenols, more attention will be directed to these promising candidates as effective adjunct therapies against metastatic breast cancer in the clinic.

10 March 2017 in Journal of Radioanalytical and Nuclear Chemistry
Verified
Journal Article
Closed access
PDF file
JCJianhua Cao
Jianhua Cao
YLYajing Liu
Yajing Liu
LZLifang Zhang
Lifang Zhang
FDFenghua Du
Fenghua Du
YCYingqian Ci
Yingqian Ci
JQJinping Qiao
Jinping Qiao

21 September 2011 in Pharmaceutical Biology
Verified
Journal Article
Open access
PDF file
MHMei Han
Mei Han
YLYing Liu
Ying Liu
BZBing Zhang
Bing Zhang
JQJinping Qiao
Jinping Qiao
WLWeidong Lu
Weidong Lu
CZChangqi Zhao
Changqi Zhao
Context: The destabilization of β-amyloid (Aβ) peptide aggregates and the protection of functional cells are the attractive therapeutic strategies for Alzheimer’s disease (AD). Some active ingredients of Salvia miltiorrhiza f. alba C.Y.Wu & H.W.Li (Lamiaceae) (SM) have attracted increasing attention for the treatment of neurodegenerative diseases. Objective: Salvianic borneol ester (SBE) is a new compound based on SM formulas. The present study was designed to examine the anti-amyloid effects and neuroprotection of SBE in vitro. Materials and methods: The destabilizing effects of SBE and its related compounds (salvianic acid A and borneol) on preformed Aβ oligomers were measured by using fluorescence spectroscopy with thioflavin T (ThT) and the destabilizing effects of SBE were further confirmed visually by transmission electron microscopy (TEM). The neuroprotective effects of SBE against hydrogen peroxide (H2O2)-induced toxicity in human neuroblastoma cells (SH-SY5Y) and motor neuron hybridoma cells (VSC 4.1) were shown by MTT assay and morphological observation. Results: SBE showed the most significant destabilizing effect, though the mixture of salvianic acid A and borneol also destabilized Aβ1–40 oligomers. The destabilizing activity of salvianic acid A or borneol alone was not significant. SBE destabilized Aβ1–40 oligomers in dose- and time-dependent manners and the destabilizing effect could also be seen in the photographs of TEM. Furthermore, SBE could protect SH-SY5Y cells and VSC 4.1 cells against H2O2-induced toxicity in a dose-dependent manner. Discussion and conclusion: SBE had the bifunctional activities of anti-amyloid and neuroprotection. It may have therapeutic potential for AD and be an alternative lead compound for developing new drugs against AD.

4 September 2019 in Drug Testing and Analysis
Verified
Journal Article
Closed access
PDF file
HLHuajun Li
Huajun Li
QTQi Tan
Qi Tan
YZYubo Zhang
Yubo Zhang
JZJing Zhang
Jing Zhang
CZChaoran Zhao
Chaoran Zhao
MHMei Han
Mei Han